2018
DOI: 10.1016/j.jacc.2018.04.053
|View full text |Cite
|
Sign up to set email alerts
|

Association of IL-8 With Infarct Size and Clinical Outcomes in Patients With STEMI

Abstract: High levels of circulating IL-8 were associated with large infarct size, impaired recovery of LV function, and adverse clinical outcome in patients with STEMI, suggesting IL-8 as a future therapeutic target based on its important role in post-infarction inflammation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
29
0
3

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 48 publications
(38 citation statements)
references
References 24 publications
5
29
0
3
Order By: Relevance
“…These results are consistent with what we previously reported, serum IL-8 expression was increased in acute myocardial infarctions (AMI) patients, and a higher serum IL-11 level was found in unstable angina pectoris group [30]. Other research groups have demonstrated that high levels of circulating IL-8 were associated with large infarct size, impaired recovery of left ventricular function, and adverse clinical outcome in patients with CAD [31][32][33][34][35]; Yao et al showed IL-11 was increased in thoracic aorta and plasma of acute thoracic aortic dissection (TAD) patients and may be a promising biomarker for diagnosis in patients with TAD [36].…”
Section: Discussionsupporting
confidence: 92%
“…These results are consistent with what we previously reported, serum IL-8 expression was increased in acute myocardial infarctions (AMI) patients, and a higher serum IL-11 level was found in unstable angina pectoris group [30]. Other research groups have demonstrated that high levels of circulating IL-8 were associated with large infarct size, impaired recovery of left ventricular function, and adverse clinical outcome in patients with CAD [31][32][33][34][35]; Yao et al showed IL-11 was increased in thoracic aorta and plasma of acute thoracic aortic dissection (TAD) patients and may be a promising biomarker for diagnosis in patients with TAD [36].…”
Section: Discussionsupporting
confidence: 92%
“…These results are consistent with what we previously reported, serum IL-8 expression was increased in acute myocardial infarctions (AMI) patients, and a higher serum IL-11 level was found in unstable angina pectoris group[30]. Other research groups have demonstrated that high levels of circulating IL-8 were associated with large infarct size, impaired recovery of left ventricular function, and adverse clinical outcome in patients with CAD[31][32][33][34][35]; Yao et al showed IL-11 was increased in thoracic aorta and plasma of acute thoracic aortic dissection (TAD) patients and may be a promising biomarker for diagnosis in patients with TAD[36]. 1R1 with IL-1ra (anakinra) is sufficient to attenuate the severity of acute heart failure [39].…”
supporting
confidence: 92%
“…In addition, it reported that inflammation plays a critical role of total cardiovascular disease, ischemic heart disease, and myocardial infarction [ 41 , 42 ]. Higher levels of circulating interleukin (IL)-8 were associated with larger infarct size and more adverse clinical outcomes in patients with ST-segment elevation myocardial infarction [ 43 ]. Vieira et al [ 44 ] showed targetting of the lymphatic/immune cell axis as a therapeutic paradigm to promote immune modulation and heart repair.…”
Section: Discussionmentioning
confidence: 99%